Notably, the median (IQR) time since IBD diagnosis was longer in non-IRIS cases (108 [78–162] vs 48 [25–81] months, P = .013), but the duration of anti-TNFα treatment was comparable (12 [3–30] vs 11.50 [3–46] months). Here, TNF is linked to inflammatory bowel disease.